Tranilast, a tryptophan metabolite analog, binds to NACHT domain of NLRP3, preventing NLRP3-NLRP3 interaction and alleviating the symptoms of gouty arthritis, cryopyrin-associated autoinflammatory syndromes, and type 2 diabetes (115). This evidence concerns the gene NLRP3 and gout.